Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 63

1.

Incomplete revascularization for percutaneous coronary interventions: Variation among operators, and association with operator and hospital characteristics.

Hannan EL, Zhong Y, Jacobs AK, Ling FSK, Berger PB, Walford G, Venditti FJ, King SB 3rd.

Am Heart J. 2017 Apr;186:118-126. doi: 10.1016/j.ahj.2017.01.015. Epub 2017 Feb 8.

PMID:
28454825
2.

Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria.

Hannan EL, Samadashvili Z, Cozzens K, Gesten F, Osinaga A, Fish DG, Donahue CL, Bass RJ, Walford G, Jacobs AK, Venditti FJ, Stamato NJ, Berger PB, Sharma S, King SB 3rd.

J Am Coll Cardiol. 2017 Mar 14;69(10):1234-1242. doi: 10.1016/j.jacc.2016.12.025.

PMID:
28279289
3.

The Impact of Excluding Shock Patients on Hospital and Physician Risk-Adjusted Mortality Rates for Percutaneous Coronary Interventions: The Implications for Public Reporting.

Hannan EL, Zhong Y, Cozzens K, Gesten F, Friedrich M, Berger PB, Jacobs AK, Walford G, Ling FS, Venditti FJ, King SB 3rd.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):224-231. doi: 10.1016/j.jcin.2016.10.040.

PMID:
28183462
4.

Patients With Chronic Total Occlusions Undergoing Percutaneous Coronary Interventions: Characteristics, Success, and Outcomes.

Hannan EL, Zhong Y, Jacobs AK, Stamato NJ, Berger PB, Walford G, Sharma S, Venditti FJ, King SB 3rd.

Circ Cardiovasc Interv. 2016 May;9(5):e003586. doi: 10.1161/CIRCINTERVENTIONS.116.003586.

5.

Appending Limited Clinical Data to an Administrative Database for Acute Myocardial Infarction Patients: The Impact on the Assessment of Hospital Quality.

Hannan EL, Samadashvili Z, Cozzens K, Jacobs AK, Venditti FJ, Holmes DR Jr, Berger PB, Stamato NJ, Hughes S, Walford G.

Med Care. 2016 May;54(5):538-45. doi: 10.1097/MLR.0000000000000520.

PMID:
27078825
6.

Ozone exposure and systemic biomarkers: Evaluation of evidence for adverse cardiovascular health impacts.

Goodman JE, Prueitt RL, Sax SN, Pizzurro DM, Lynch HN, Zu K, Venditti FJ.

Crit Rev Toxicol. 2015 May;45(5):412-52. doi: 10.3109/10408444.2015.1031371. Review.

PMID:
25959700
7.

Reply: Is CABG Superior to DES for Repeat Revascularization in Patients With Isolated Proximal LAD Disease?

Hannan EL, Zhong Y, Walford G, Holmes DR Jr, Venditti FJ, Berger PB, Jacobs AK, Stamato NJ, Curtis JP, Sharma S, King SB 3rd.

J Am Coll Cardiol. 2015 Apr 28;65(16):1716. doi: 10.1016/j.jacc.2015.02.030. No abstract available.

8.

Mechanisms of action for arsenic in cardiovascular toxicity and implications for risk assessment.

Sidhu MS, Desai KP, Lynch HN, Rhomberg LR, Beck BD, Venditti FJ.

Toxicology. 2015 May 4;331:78-99. doi: 10.1016/j.tox.2015.02.008. Epub 2015 Mar 11. Review.

PMID:
25771173
9.

Assessing hospital performance for acute myocardial infarction: how should emergency department transfers be attributed.

Samadashvili Z, Hannan EL, Cozzens K, Walford G, Jacobs AK, Berger PB, Holmes DR Jr, Venditti FJ, Curtis J.

Med Care. 2015 Mar;53(3):245-52. doi: 10.1097/MLR.0000000000000305.

PMID:
25675402
10.

Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease.

Hannan EL, Zhong Y, Walford G, Holmes DR Jr, Venditti FJ, Berger PB, Jacobs AK, Stamato NJ, Curtis JP, Sharma S, King SB 3rd.

J Am Coll Cardiol. 2014 Dec 30;64(25):2717-26. doi: 10.1016/j.jacc.2014.09.074.

11.

Weight-of-evidence evaluation of long-term ozone exposure and cardiovascular effects.

Prueitt RL, Lynch HN, Zu K, Sax SN, Venditti FJ, Goodman JE.

Crit Rev Toxicol. 2014 Oct;44(9):791-822. doi: 10.3109/10408444.2014.937855. Review.

PMID:
25257962
12.

Weight-of-evidence evaluation of short-term ozone exposure and cardiovascular effects.

Goodman JE, Prueitt RL, Sax SN, Lynch HN, Zu K, Lemay JC, King JM, Venditti FJ.

Crit Rev Toxicol. 2014 Oct;44(9):725-90. doi: 10.3109/10408444.2014.937854. Review.

PMID:
25257961
13.

Utilization of radial artery access for percutaneous coronary intervention for ST-segment elevation myocardial infarction in New York.

Hannan EL, Farrell LS, Walford G, Berger PB, Stamato NJ, Venditti FJ, Jacobs AK, Holmes DR Jr, Sharma S, King SB 3rd.

JACC Cardiovasc Interv. 2014 Mar;7(3):276-83. doi: 10.1016/j.jcin.2013.10.020. Epub 2014 Feb 13.

14.

Appropriateness of diagnostic catheterization for suspected coronary artery disease in New York State.

Hannan EL, Samadashvili Z, Cozzens K, Walford G, Holmes DR Jr, Jacobs AK, Stamato NJ, Venditti FJ, Sharma S, King SB 3rd.

Circ Cardiovasc Interv. 2014 Feb;7(1):19-27. doi: 10.1161/CIRCINTERVENTIONS.113.000741. Epub 2014 Jan 28.

15.

Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of age.

Hannan EL, Zhong Y, Berger PB, Walford G, Curtis JP, Wu C, Venditti FJ, Higgins RS, Smith CR, Lahey SJ, King SB 3rd.

Am J Cardiol. 2014 Mar 1;113(5):803-8. doi: 10.1016/j.amjcard.2013.11.035. Epub 2013 Dec 12.

PMID:
24440331
16.

Risk stratification for long-term mortality after percutaneous coronary intervention.

Wu C, Camacho FT, King SB 3rd, Walford G, Holmes DR Jr, Stamato NJ, Berger PB, Sharma S, Curtis JP, Venditti FJ, Jacobs AK, Hannan EL.

Circ Cardiovasc Interv. 2014 Feb;7(1):80-7. doi: 10.1161/CIRCINTERVENTIONS.113.000475. Epub 2014 Jan 14.

17.

Assessment of the new appropriate use criteria for diagnostic catheterization in the detection of coronary artery disease following noninvasive stress testing.

Hannan EL, Samadashvili Z, Cozzens K, Walford G, Jacobs AK, Holmes DR Jr, Stamato NJ, Venditti FJ, Gold JP, Sharma S, King SB 3rd.

Int J Cardiol. 2014 Jan 1;170(3):371-5. doi: 10.1016/j.ijcard.2013.11.016. Epub 2013 Nov 13.

PMID:
24284007
18.

Underutilization of percutaneous coronary intervention for ST-elevation myocardial infarction in medicaid patients relative to private insurance patients.

Hannan EL, Zhong Y, Walford G, Jacobs AK, Venditti FJ, Stamato NJ, Holmes DR Jr, Sharma S, Gesten F, King SB 3rd.

J Interv Cardiol. 2013 Oct;26(5):470-81. doi: 10.1111/joic.12059. Epub 2013 Aug 20.

PMID:
23962131
19.

Incomplete revascularization is associated with greater risk of long-term mortality after stenting in the era of first generation drug-eluting stents.

Wu C, Dyer AM, Walford G, Holmes DR Jr, King SB 3rd, Stamato NJ, Sharma S, Jacobs AK, Venditti FJ, Hannan EL.

Am J Cardiol. 2013 Sep 15;112(6):775-81. doi: 10.1016/j.amjcard.2013.05.003. Epub 2013 Jun 4.

20.

Staged versus one-time complete revascularization with percutaneous coronary intervention for multivessel coronary artery disease patients without ST-elevation myocardial infarction.

Hannan EL, Samadashvili Z, Walford G, Jacobs AK, Stamato NJ, Venditti FJ, Holmes DR Jr, Sharma S, King SB 3rd.

Circ Cardiovasc Interv. 2013 Feb;6(1):12-20. doi: 10.1161/CIRCINTERVENTIONS.112.974485. Epub 2013 Jan 15.

Supplemental Content

Loading ...
Support Center